Bioniche



December 21, 2011 Bioniche Life Sciences Inc. Enters into Two Distribution Agreements for New Animal Health Products December 13, 2011 Bioniche E. coli Vaccine Granted Import Access to Australia
Latest TSX stock price All prices delayed at least 15 minutes. Source: TSX Inc. Latest ASX stock price All prices delayed at least 20 minutes. Source: ASX Inc.

Firm	Analyst	Contact Information
Northland Capital Partners	Tania Maciver	Phone: 416-987-4616
Taylor Collison Limited	Thomas Duthy	Phone: +61 2 9377 1500 Click here for report

Bioniche Life Sciences Inc. is covered by the analysts listed above. Please note that any opinions, estimates or forecasts regarding the Company’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Bioniche Life Sciences or its management. Bioniche Life Sciences does not by its reference above or distribution imply any endorsement of or concurrence with such information, conclusions or recommendations.